RA Capital Management, L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:40 pm Unchanged | 2026-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 2,611,733 4.800% | 0 (Unchanged) | Filing |
| 2026-02-17 4:25 pm Sale | 2025-12-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 2,611,733 6.000% | -1,255,000 (-32.46%) | Filing |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 3,866,733 9.500% | 1,000,000 (+34.88%) | Filing |
| 2025-05-15 4:55 pm Unchanged | 2025-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 2,866,733 8.900% | 0 (Unchanged) | Filing |
| 2025-02-14 6:32 pm Sale | 2024-12-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 2,866,733 9.400% | -128,290 (-4.28%) | Filing |
| 2024-02-01 6:22 pm Purchase | 2024-01-22 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 2,995,023 9.990% | 2,995,023 (New Position) | Filing |